Anna Katherine Krawisz, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peripheral Arterial Disease | 8 | 2024 | 1303 | 2.000 |
Why?
|
Endarterectomy, Carotid | 2 | 2021 | 557 | 1.020 |
Why?
|
Carotid Stenosis | 2 | 2021 | 862 | 0.890 |
Why?
|
Endovascular Procedures | 3 | 2023 | 2215 | 0.890 |
Why?
|
Femoral Artery | 4 | 2023 | 829 | 0.860 |
Why?
|
Popliteal Artery | 3 | 2021 | 313 | 0.820 |
Why?
|
Coated Materials, Biocompatible | 2 | 2021 | 311 | 0.790 |
Why?
|
Intermittent Claudication | 1 | 2021 | 305 | 0.620 |
Why?
|
Drug-Eluting Stents | 2 | 2021 | 681 | 0.570 |
Why?
|
Paclitaxel | 3 | 2021 | 1736 | 0.560 |
Why?
|
Angioplasty, Balloon | 1 | 2021 | 592 | 0.560 |
Why?
|
Carotid Artery Diseases | 1 | 2021 | 878 | 0.490 |
Why?
|
Vascular Patency | 3 | 2024 | 916 | 0.480 |
Why?
|
Cardiovascular Agents | 1 | 2021 | 849 | 0.470 |
Why?
|
Healthcare Disparities | 3 | 2023 | 3413 | 0.340 |
Why?
|
Medicare | 6 | 2024 | 6881 | 0.320 |
Why?
|
Pulmonary Embolism | 3 | 2024 | 2587 | 0.250 |
Why?
|
Hypertension, Renovascular | 1 | 2024 | 115 | 0.220 |
Why?
|
Atherectomy | 1 | 2023 | 42 | 0.210 |
Why?
|
Stroke | 2 | 2021 | 9742 | 0.200 |
Why?
|
Vena Cava Filters | 1 | 2024 | 270 | 0.190 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2024 | 291 | 0.190 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2024 | 465 | 0.170 |
Why?
|
Device Removal | 1 | 2024 | 643 | 0.170 |
Why?
|
Stents | 2 | 2021 | 3201 | 0.160 |
Why?
|
Limb Salvage | 1 | 2022 | 489 | 0.160 |
Why?
|
DiGeorge Syndrome | 1 | 2020 | 187 | 0.160 |
Why?
|
Treatment Outcome | 8 | 2024 | 65379 | 0.150 |
Why?
|
Exercise Therapy | 1 | 2024 | 941 | 0.140 |
Why?
|
Hypolipidemic Agents | 1 | 2021 | 609 | 0.140 |
Why?
|
Angioplasty | 1 | 2019 | 357 | 0.130 |
Why?
|
United States | 9 | 2024 | 73150 | 0.130 |
Why?
|
Calcium Signaling | 1 | 2020 | 739 | 0.130 |
Why?
|
Venous Thrombosis | 1 | 2024 | 1317 | 0.120 |
Why?
|
Renal Dialysis | 1 | 2024 | 1802 | 0.120 |
Why?
|
Risk Factors | 5 | 2024 | 74962 | 0.100 |
Why?
|
Self Tolerance | 1 | 2013 | 123 | 0.100 |
Why?
|
Kidney Failure, Chronic | 1 | 2024 | 2491 | 0.100 |
Why?
|
Risk Assessment | 3 | 2021 | 24318 | 0.090 |
Why?
|
Aged | 9 | 2024 | 171562 | 0.090 |
Why?
|
Chromosome Disorders | 1 | 2013 | 499 | 0.090 |
Why?
|
Patient Discharge | 1 | 2024 | 3476 | 0.090 |
Why?
|
Lipids | 1 | 2021 | 3344 | 0.090 |
Why?
|
Humans | 18 | 2024 | 768393 | 0.080 |
Why?
|
Retrospective Studies | 6 | 2024 | 81801 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1882 | 0.080 |
Why?
|
Thymus Gland | 1 | 2013 | 1266 | 0.080 |
Why?
|
Polyendocrinopathies, Autoimmune | 1 | 2008 | 56 | 0.080 |
Why?
|
Neurons | 2 | 2020 | 9513 | 0.070 |
Why?
|
Mortality | 1 | 2019 | 2917 | 0.070 |
Why?
|
Aged, 80 and over | 5 | 2024 | 59686 | 0.070 |
Why?
|
Female | 13 | 2024 | 397089 | 0.070 |
Why?
|
Male | 11 | 2024 | 364902 | 0.070 |
Why?
|
Hospital Mortality | 1 | 2021 | 5367 | 0.070 |
Why?
|
Incidence | 2 | 2024 | 21544 | 0.070 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2013 | 1943 | 0.060 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14784 | 0.060 |
Why?
|
Registries | 1 | 2021 | 8379 | 0.060 |
Why?
|
Cerebral Cortex | 1 | 2020 | 5831 | 0.060 |
Why?
|
Synapses | 1 | 2013 | 1766 | 0.060 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2013 | 4411 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15939 | 0.050 |
Why?
|
Insurance Benefits | 1 | 2024 | 187 | 0.050 |
Why?
|
Epithelial Cells | 1 | 2013 | 3695 | 0.050 |
Why?
|
Nerve Tissue Proteins | 1 | 2013 | 4414 | 0.040 |
Why?
|
Hospitalization | 1 | 2020 | 10844 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2021 | 11516 | 0.040 |
Why?
|
Fee-for-Service Plans | 1 | 2024 | 714 | 0.040 |
Why?
|
Tubulin Modulators | 1 | 2019 | 106 | 0.040 |
Why?
|
Mice, Inbred NOD | 2 | 2013 | 1839 | 0.030 |
Why?
|
Minority Groups | 1 | 2023 | 1215 | 0.030 |
Why?
|
Transcription Factors | 2 | 2013 | 12166 | 0.030 |
Why?
|
Organoids | 1 | 2020 | 746 | 0.030 |
Why?
|
GABA Agents | 1 | 2013 | 41 | 0.030 |
Why?
|
Extremities | 1 | 2019 | 870 | 0.030 |
Why?
|
Adult | 3 | 2024 | 223640 | 0.030 |
Why?
|
Receptors, Glutamate | 1 | 2013 | 229 | 0.030 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2013 | 348 | 0.030 |
Why?
|
Middle Aged | 5 | 2024 | 223491 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2013 | 824 | 0.020 |
Why?
|
Lentivirus | 1 | 2013 | 519 | 0.020 |
Why?
|
Acute Disease | 1 | 2020 | 7242 | 0.020 |
Why?
|
Antigen-Presenting Cells | 1 | 2013 | 962 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2020 | 11668 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2013 | 1497 | 0.020 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2013 | 1438 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2013 | 1390 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2020 | 1889 | 0.020 |
Why?
|
Antigen Presentation | 1 | 2013 | 1251 | 0.020 |
Why?
|
Synaptic Transmission | 1 | 2013 | 1175 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2013 | 1614 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10654 | 0.020 |
Why?
|
Pluripotent Stem Cells | 1 | 2013 | 808 | 0.020 |
Why?
|
Lymphocyte Depletion | 1 | 2008 | 605 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10588 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2013 | 2414 | 0.020 |
Why?
|
Autoimmunity | 1 | 2013 | 1360 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2013 | 1999 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 8075 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2024 | 7955 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 26375 | 0.010 |
Why?
|
Syndrome | 1 | 2008 | 3275 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10377 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9562 | 0.010 |
Why?
|
Mice | 3 | 2013 | 82017 | 0.010 |
Why?
|
Cell Line | 1 | 2013 | 15597 | 0.010 |
Why?
|
Trans-Activators | 1 | 2008 | 2856 | 0.010 |
Why?
|
Animals | 3 | 2013 | 169337 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11918 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2008 | 4646 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2008 | 5800 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 60049 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2008 | 14481 | 0.010 |
Why?
|
Signal Transduction | 1 | 2013 | 23631 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2008 | 22355 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2008 | 18362 | 0.000 |
Why?
|
Child | 1 | 2013 | 80891 | 0.000 |
Why?
|